Dear Women's Imaging Insider,
During the past decade, breast imaging has accounted for almost 20% of patients' allegations involving radiology practice in the Netherlands. That's one of the key findings of a new analysis published this week in European Radiology.
The good news, though, is that the total number of legal cases remains reassuringly low -- probably because a compensation culture hasn't become established yet, the authors say. Don't miss our report posted today.
The double reading of a mammogram, followed by a consensus review when the recommendations don't align, is established practice across much of Europe, but what impact does it actually have on recall rates and cancer detection? A team of global researchers has attempted to answer this question, and its findings are worth an inspection.
Breast MRI has many potential benefits, particularly its sensitivity, but a downside seems to be the relatively high recall rate. Researchers from leading facilities in Dublin have looked closely at this issue, and their results deserve scrutiny. While we're thinking about breast MRI, the results are expected soon for the EA1141 multicenter study on abbreviated MRI compared with tomosynthesis for breast cancer screening. We intend to cover that study, too, so watch this space over the next week or so.
Meanwhile, from Italy we have an article about why women miss breast screening appointments. The authors called a random selection of nearly 1,500 individuals from the 2017 cancer screening program who had failed to attend.
Also, Dutch researchers have presented new data on breast microcalcifications, having looked at two decades of mammography screening results from hundreds of thousands of women.
This letter features only a few of the reports posted over the past month or so in the Women's Imaging Community. Please scroll through the full list of our coverage below.
